O
30
-3
MLM
67
9
EMN
55
6
KEY
53
19
KSS
38
-4
ADT
56
6
AVY
47
-6
EXPD
40
-5
MAT
47
-12
GD
53
9
URI
72
13
ACN
47
9
MTB
68
12
QCOM
62
11
EXPE
80
3
HD
41
-8
EFX
38
-2
GME
59
2
MAC
65
-3
CPB
24
-6
O
30
-3
MLM
67
9
EMN
55
6
KEY
53
19
KSS
38
-4
ADT
56
6
AVY
47
-6
EXPD
40
-5
MAT
47
-12
GD
53
9
URI
72
13
ACN
47
9
MTB
68
12
QCOM
62
11
EXPE
80
3
HD
41
-8
EFX
38
-2
GME
59
2
MAC
65
-3
CPB
24
-6
Financhill
Back

Range Cancer Therapeutics ETF Stock Predictions

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
63

CNCR
Range Cancer Therapeutics ETF

Last Price:
15.58
Seasonality Move:
8.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Range Cancer Therapeutics ETF Stock Forecast

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically risen by 2.6% based on the past 9 years of stock performance.
  • Range Cancer Therapeutics ETF has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Range Cancer Therapeutics ETF Stock Undervalued?
    The current Range Cancer Therapeutics ETF [CNCR] share price is $15.59. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Range Cancer Therapeutics ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Range Cancer Therapeutics ETF has on average historically risen by 2.6% based on the past 9 years of stock performance.

Range Cancer Therapeutics ETF Stock Rating

Buy
63
Range Cancer Therapeutics ETF (CNCR) is a Buy

Is Range Cancer Therapeutics ETF overpriced?

  • Range Cancer Therapeutics ETF has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Range Cancer Therapeutics ETF Stock Price History

Is CNCR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
17.96
52-Week Low:
9.52

Prediction Charts

Market Cap:
0
Price in USD:
15.59
Volume:
3.1K
Beta:
1.11

Technical Analysis

SMA50:
15.01
SMA100:
14.69
SMA200:
15.06
52-Wk Change:
49.4%

Stock Predictions

  • Is Range Cancer Therapeutics ETF stock public?
    Yes, Range Cancer Therapeutics ETF is a publicly traded company.
  • What is the Range Cancer Therapeutics ETF stock quote today?
    The Range Cancer Therapeutics ETF stock price is 15.59 USD today.
  • How to buy Range Cancer Therapeutics ETF stock online?
    You can buy Range Cancer Therapeutics ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-18 15.25 15.36 15.36 15.20
Oct-21 15.36 15.10 15.36 14.98
Oct-22 14.97 15.22 15.22 14.97
Oct-23 15.17 14.89 15.17 14.71
Oct-24 14.91 14.84 15.10 14.84
Oct-25 14.85 14.69 14.85 14.69
Oct-28 15.05 15.29 15.34 15.05
Oct-29 15.11 15.03 15.11 14.99
Oct-30 14.90 14.90 14.90 14.90
Oct-31 14.87 14.58 14.87 14.58
Nov-1 14.67 14.74 14.78 14.67
Nov-4 14.96 14.96 14.96 14.96
Nov-5 15.01 15.16 15.16 15.01
Nov-6 15.59 15.59 15.73 15.46

Range Cancer Therapeutics ETF Earnings

Data Unavailable

Range Cancer Therapeutics ETF Forecast Revenue Growth

Data Unavailable

* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.